Tümör Mikroçevresi ve Hücresel Etkileşimler
Özet
Referanslar
Mayer S, Milo T, Isaacson A, et al. The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts. Nature Communications. 2023;14(1):5810. doi:10.1038/s41467-023-41518-w
Yu S, Wang S, Wang X, et al. The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis. Cancer Cell International. 2024;24:335. doi:10.1186/s12935-024-03518-8
Arneth B. Tumor microenvironment. Medicina. 2020;56(1):15. doi:10.3390/medicina56010015
Almazrouei KM, Mishra V, Pandya H, et al. Tumor microenvironment and its role in cancer progression: an integrative review. Cureus. 2025;17(9):e92707. doi:10.7759/cureus.92707
Desai SA, Patel VP, Bhosle KP, Nagare SD, Thombare KC. The tumor microenvironment: shaping cancer progression and treatment response. Journal of Chemotherapy. 2025;37(1):15–44. doi:10.1080/1120009X.2023.2300224
Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Molecular Cancer. 2021;20:131. doi:10.1186/s12943-021-01428-1
Zhang Y, Wang C, Li JJ. Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression. Experimental Hematology & Oncology. 2024;13:64. doi:10.1186/s40164-024-00532-4
Zhang F, Ma Y, Li D, et al. Cancer-associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. Journal of Hematology & Oncology. 2024;17:80. doi:10.1186/s13045-024-01600-2
Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling. 2020;18:59. doi:10.1186/s12964-020-0530-4
Wei R, Liu S, Zhang S, et al. Cellular and extracellular components in tumor microenvironment and their application in early diagnosis of cancers. Analytical Cellular Pathology. 2020;2020:6283796. doi:10.1155/2020/6283796
Biray Avci C, Goker Bagca B, Nikanfar M, et al. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Frontiers in Pharmacology. 2024;15:1442888. doi:10.3389/fphar.2024.1442888
Shoucair I, Weber Mello F, Jabalee J, et al. The role of cancer-associated fibroblasts and extracellular vesicles in tumorigenesis. International Journal of Molecular Sciences. 2020;21(18):6837. doi:10.3390/ijms21186837
Wright K, Ly T, Kriet M, et al. Cancer-associated fibroblasts: master tumor microenvironment modifiers. Cancers. 2023;15(6):1899. doi:10.3390/cancers15061899
Nedaeinia R, Najafgholian S, Salehi R, et al. The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review. Cell Death Discovery. 2024;10(1):380. doi:10.1038/s41420-024-02146-5
Gao J, Zhang X, Jiang L, et al. Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling. Cell Communication and Signaling. 2022;20:97. doi:10.1186/s12964-022-00904-5
Zhao Y, Shen M, Wu L, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death & Disease. 2023;14(9):587. doi:10.1038/s41419-023-06110-6
Li YR, Fang Y, Lyu Z, et al. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. Journal of Translational Medicine. 2023;21:686. doi:10.1186/s12967-023-04575-9
Marozzi M, Parnigoni A, Negri A, et al. Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment. International Journal of Molecular Sciences. 2021;22(15):8102. doi:10.3390/ijms22158102
Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling. 2020;18:59. doi:10.1186/s12964-020-0530-4
Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. Journal of Biomedical Science. 2022;29(1):83. doi:10.1186/s12929-022-00866-3
Prieto-Vila M, Yoshioka Y, Ochiya T. Biological functions driven by mRNAs carried by extracellular vesicles in cancer. Frontiers in Cell and Developmental Biology. 2021;9:620498. doi:10.3389/fcell.2021.620498
Guo S, Deng CX. Effect of stromal cells in tumor microenvironment on metastasis initiation. International Journal of Biological Sciences. 2018;14(14):2083–2093. doi:10.7150/ijbs.25720
Mitchell MI, Loudig O. Communicator extraordinaire: extracellular vesicles in the tumor microenvironment are essential local and long-distance mediators of cancer metastasis. Biomedicines. 2023;11(9):2534. doi:10.3390/biomedicines11092534
Peng Z, Tong Z, Ren Z, et al. Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment. Molecular Medicine. 2023;29(1):66. doi:10.1186/s10020-023-00665-y
Ten A, Kumeiko V, Farniev V, et al. Tumor microenvironment modulation by cancer-derived extracellular vesicles. Cells. 2024;13(8):682. doi:10.3390/cells13080682
Bussard KM, Mutkus L, Stumpf K, et al. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Research. 2016;18(1):84. doi:10.1186/s13058-016-0740-2
Frisbie L, Buckanovich RJ, Coffman L. Carcinoma-associated mesenchymal stem/stromal cells: architects of the pro-tumorigenic tumor microenvironment. Stem Cells. 2022;40(8):705–715. doi:10.1093/stmcls/sxac036
Sun L, Cao X, Zhou B, et al. Tumor-associated mesenchymal stem/stromal cells in tumor microenvironment and carcinogenesis. Experimental Hematology & Oncology. 2025;14:97. doi:10.1186/s40164-025-00688-7
Guo T, Xu J. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer Metastasis Reviews. 2024;43(3):1095–1116. doi:10.1007/s10555-024-10186-7
Yang D, Liu J, Qian H, et al. Cancer-associated fibroblasts: from basic science to anticancer therapy. Experimental & Molecular Medicine. 2023;55(7):1322–1332. doi:10.1038/s12276-023-01013-0
Jia H, Chen X, Zhang L, et al. Cancer-associated fibroblasts in cancer development and therapy. Journal of Hematology & Oncology. 2025;18(1):36. doi:10.1186/s13045-025-01688-0
Liu T, Han C, Wang S, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. Journal of Hematology & Oncology. 2019;12:86. doi:10.1186/s13045-019-0770-1
El Alaa RSA, Al-Mannai W, Darwish N, et al. Adipose-derived stromal cells and cancer-associated fibroblasts: interactions and implications in tumor progression. International Journal of Molecular Sciences. 2024;25(21):11558. doi:10.3390/ijms252111558
Ghebremedhin A, Athavale D, Zhang Y, et al. Tumor-associated macrophages as major immunosuppressive cells in the tumor microenvironment. Cancers. 2024;16(19):3410. doi:10.3390/cancers16193410
Yang Y, Li S, To KKW, et al. Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy. Journal of Experimental & Clinical Cancer Research. 2025;44(1):145. doi:10.1186/s13046-025-03377-9
Chen Y, Song Y, Du W, et al. Tumor-associated macrophages: an accomplice in solid tumor progression. Journal of Biomedical Science. 2019;26:78. doi:10.1186/s12929-019-0568-z
Hourani T, Holden JA, Li W, et al. Tumor-associated macrophages: origin, recruitment, phenotypic diversity, and targeting. Frontiers in Oncology. 2021;11:788365. doi:10.3389/fonc.2021.788365
Saeed AF. Tumor-associated macrophages: polarization, immunoregulation, and immunotherapy. Cells. 2025;14(10):741. doi:10.3390/cells14100741
Goswami KK, Bose A, Baral R. Macrophages in tumor: an inflammatory perspective. Clinical Immunology. 2021;232:108875. doi:10.1016/j.clim.2021.108875
Karimova AF, Khalitova AR, Suezov R, et al. Immunometabolism of tumor-associated macrophages: A therapeutic perspective. European Journal of Cancer. 2025;220:115332. doi:10.1016/j.ejca.2025.115332
Qian Y, Yin Y, Zheng X, et al. Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities. Biomarker Research. 2024;12:1. doi:10.1186/s40364-023-00549-7
Kumari N, Choi SH. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies. Journal of Experimental & Clinical Cancer Research. 2022;41:68. doi:10.1186/s13046-022-02272-x
Yan S, Wan G. Tumor-associated macrophages in immunotherapy. FEBS Journal. 2021;288(21):6174–6186. doi:10.1111/febs.15726
Dzobo K, Dandara C. The extracellular matrix: its composition, function, remodeling, and role in tumorigenesis. Biomimetics. 2023;8(2):146. doi:10.3390/biomimetics8020146
Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Experimental Hematology & Oncology. 2025;14(1):54. doi:10.1186/s40164-025-00647-2
Raskov H, Gaggar S, Tajik A, et al. The matrix reloaded—the role of the extracellular matrix in cancer. Cancers. 2023;15(7):2057. doi:10.3390/cancers15072057
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52–67. doi:10.1016/j.cell.2010.03.015
Niland S, Riscanevo AX, Eble JA. Matrix metalloproteinases shape the tumor microenvironment in cancer progression. International Journal of Molecular Sciences. 2021;23(1):146. doi:10.3390/ijms23010146
Popova NV, Jücker M. The functional role of extracellular matrix proteins in cancer. Cancers. 2022;14(1):238. doi:10.3390/cancers14010238
Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clinical & Experimental Metastasis. 2019;36(3):171–198. doi:10.1007/s10585-019-09966-1
Yuan Z, Li Y, Zhang S, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Molecular Cancer. 2023;22(1):48. doi:10.1186/s12943-023-01744-8
Jiang X, Wang J, Deng X, et al. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research. 2020;39(1):204. doi:10.1186/s13046-020-01709-5
Nyberg P, Salo T, Kalluri R. Tumor microenvironment and angiogenesis. Frontiers in Bioscience. 2008;13(17):6537–6553. doi:10.2741/3173
Kaur G, Roy B. Decoding tumor angiogenesis for therapeutic advancements: mechanistic insights. Biomedicines. 2024;12(4):827. doi:10.3390/biomedicines12040827
Quintero-Fabián S, Arreola R, Becerril-Villanueva E, et al. Role of matrix metalloproteinases in angiogenesis and cancer. Frontiers in Oncology. 2019;9:1370. doi:10.3389/fonc.2019.01370
Siddhartha R, Garg M. Interplay between extracellular matrix remodeling and angiogenesis in tumor ecosystem. Molecular Cancer Therapeutics. 2023;22(3):291–305. doi:10.1158/1535-7163.MCT-22-0595
Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvascular Research. 2007;74(2–3):72–84. doi:10.1016/j.mvr.2007.05.003
Yang S, Fang Y, Ma Y, et al. Angiogenesis and targeted therapy in the tumour microenvironment: from basic to clinical practice. Clinical and Translational Medicine. 2025;15(4):e70313. doi:10.1002/ctm2.70313
Zhou Z, Zhong H, Wang H, et al. Microenvironmental regulation and remodeling of breast cancer angiogenesis: from basic mechanisms to clinical therapeutic implications. Discover Oncology. 2025;16(1):1973. doi:10.1007/s12672-025-03797-1
Zhang X, Ma H, Gao Y, et al. The tumor microenvironment: signal transduction. Biomolecules. 2024;14(4):438. doi:10.3390/biom14040438
Abdul-Rahman T, Ghosh S, Badar SM, et al. The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review. European Journal of Medical Research. 2024;29(1):124. doi:10.1186/s40001-024-01711-z
Shi R, Tang YQ, Miao H. Metabolism in tumor microenvironment: implications for cancer immunotherapy. MedComm. 2020;1(1):47–68. doi:10.1002/mco2.6
De Goede KE, Driessen AJM, Van den Bossche J. Metabolic cancer–macrophage crosstalk in the tumor microenvironment. Biology. 2020;9(11):380. doi:10.3390/biology9110380
Zhang H, Li S, Wang D, et al. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomarker Research. 2024;12:96. doi:10.1186/s40364-024-00646-1
Zhu Y, Li X, Wang L, et al. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment. Frontiers in Endocrinology. 2022;13:988295. doi:10.3389/fendo.2022.988295
Lin J, Rao D, Zhang M, et al. Metabolic reprogramming in the tumor microenvironment of liver cancer. Journal of Hematology & Oncology. 2024;17:6. doi:10.1186/s13045-024-01527-8
Xie Y, Wang X, Wang W, et al. Epithelial–mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges. Journal of Translational Medicine. 2025;23(1):386. doi:10.1186/s12967-025-06422-5
Gloushankova NA, Zhitnyak IY, Rubtsova SN. Role of epithelial–mesenchymal transition in tumor progression. Biochemistry (Moscow). 2018;83(12):1469–1476. doi:10.1134/S0006297918120052
Lu J, Kornmann M, Traub B. Role of epithelial to mesenchymal transition in colorectal cancer. International Journal of Molecular Sciences. 2023;24(19):14815. doi:10.3390/ijms241914815
Atiya HI, Gorecki G, Garcia GL, et al. Stromal-modulated epithelial-to-mesenchymal transition in cancer cells. Biomolecules. 2023;13(11):1604. doi:10.3390/biom13111604
Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. Journal of Cellular Biochemistry. 2007;101(4):816–829. doi:10.1002/jcb.21215
Yuan J, Yang L, Zhang H, et al. Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance. Biomedicine & Pharmacotherapy. 2024;181:117714. doi:10.1016/j.biopha.2024.117714
Lu J, Kornmann M, Traub B. Role of epithelial to mesenchymal transition in colorectal cancer. International Journal of Molecular Sciences. 2023;24(19):14815. doi:10.3390/ijms241914815
Allgayer H, Mahapatra S, Mishra B, et al. Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models. Molecular Cancer. 2025;24:167. doi:10.1186/s12943-025-02338-2
Glaviano A, Lau HSH, Carter LM, et al. Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial–mesenchymal transition. Journal of Hematology & Oncology. 2025;18:6. doi:10.1186/s13045-024-01634-6
Li Z, Li J, Bai X, et al. Tumor microenvironment as a complex milieu driving cancer progression: a mini review. Clinical and Translational Oncology. 2025;27(5):1943–1952. doi:10.1007/s12094-024-03697-w
Lefler DS, Manobianco SA, Bashir B. Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer Biology & Therapy. 2024;25(1):2315655. doi:10.1080/15384047.2024.2315655
Gupta G, Merhej G, Saravanan S, et al. Cancer resistance to immunotherapy: what is the role of cancer stem cells? Cancer Drug Resistance. 2022;5(4):981–994. doi:10.20517/cdr.2022.19
Kundu M, Butti R, Panda VK, et al. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Molecular Cancer. 2024;23(1):92. doi:10.1186/s12943-024-01990-4
Wang Y, Zhou H, Ju S, et al. The solid tumor microenvironment and related targeting strategies: a concise review. Frontiers in Immunology. 2025;16:1563858. doi:10.3389/fimmu.2025.1563858
Lopes CDH, Braganca Xavier C, Torrado C, et al. A comprehensive exploration of agents targeting tumor microenvironment: challenges and future perspectives. Journal of Immunotherapy and Precision Oncology. 2024;7(4):283–299. doi:10.36401/JIPO-24-23
Fang B, Lu Y, Li X, et al. Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer. Prostate Cancer and Prostatic Diseases. 2025;28(2):260–269. doi:10.1038/s41391-024-00825-z
Yu J, Kong X, Feng Y. Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer. Cancer Drug Resistance. 2025;8:21. doi:10.20517/cdr.2025.14
Kwantwi LB, Rosen ST, Querfeld C. The tumor microenvironment as a therapeutic target in cutaneous T cell lymphoma. Cancers. 2024;16(19):3368. doi:10.3390/cancers16193368
Datta M, et al. Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies. ASCO Educational Book. 2019;39:165–174. doi:10.1200/EDBK_237987
